Progesterone Price Trend and Forecast 2026: Latest Global Market Analysis and Industry Outlook
.png)
According to ChemAnalyst, the Progesterone Price market recorded a notable increase across major global regions during the second quarter of 2026. In the United States, the Progesterone Price Index increased by 12.44% quarter-over-quarter, with the average price reaching approximately USD 201,726.67/MT. China also registered a 12.401% QoQ increase, with an average price of around USD 201,550/MT, while Germany recorded a 12.4275% increase, reaching approximately USD 201,695/MT. India experienced a comparatively moderate 3.699% QoQ increase.
The Q2 2026 Progesterone Price Trend was primarily influenced by higher international freight costs, elevated container insurance, tighter availability of steroid feedstocks, stronger export enquiries, and controlled inventories. At the same time, steady demand from hormone replacement therapy (HRT), fertility treatments, contraceptive formulations, and veterinary applications provided support to the market.
Progesterone Price Trend in North America
In the United States, the Progesterone Price increased by 12.44% QoQ during Q2 2026. The quarterly average stood at approximately USD 201,726.67/MT. The increase was largely associated with higher freight charges, particularly on the Shanghai-to-Los Angeles route, which increased landed import costs and strengthened import parity.
Currency movements also contributed to the increase in acquisition costs. A weaker US dollar against several supplier currencies reduced the discount available to American buyers, while international logistics expenses remained elevated. Despite these cost pressures, underlying production and feedstock availability remained relatively stable, preventing a major supply shock.
The US market continued to receive support from pharmaceutical and healthcare applications. Demand from hormone replacement therapies, fertility treatments, contraceptive products, and veterinary formulations maintained regular procurement requirements. Formulators adopted cautious restocking strategies as inventories remained relatively lean.
Export offers from Asian producers also remained firm as manufacturers managed inventories and prioritized contracted shipments. As a result, the North American Progesterone Price Trend remained firm during the quarter despite balanced physical supply.
Progesterone Price Trend in Asia Pacific
The Asia Pacific market also recorded a significant increase during Q2 2026. According to ChemAnalyst, China's Progesterone Price Index rose by 12.401% QoQ, with the average price reaching approximately USD 201,550/MT on a Shanghai basis.
The increase was supported by stronger export demand and higher upstream production costs. In particular, firmer availability of diosgenin, an important steroidal precursor, increased procurement costs for manufacturers. Higher solvent costs also contributed to increased conversion expenses.
Environmental inspections affected some marginal production capacity, reducing spot availability during June. While major coastal producers continued operating near nameplate capacity, smaller or less efficient producers faced greater operating constraints.
International enquiries from fertility and veterinary pharmaceutical manufacturers supported export offers. Producers therefore maintained disciplined shipment allocations rather than aggressively expanding spot availability. This combination of feedstock pressure, export demand, and controlled inventories strengthened the Progesterone Price Trend in China.
India recorded a more moderate increase of 3.699% QoQ during Q2 2026. The Indian market was influenced by stronger domestic offtake and inventory drawdowns. Buyers maintained cautious purchasing patterns, which helped limit the pace of price increases compared with China and Western markets.
Progesterone Price Trend in Europe
Germany recorded a 12.4275% QoQ increase in the Progesterone Price Index during Q2 2026. The average price reached approximately USD 201,695/MT.
The European market faced tighter Asian feedstock availability, higher freight expenses, and increased container insurance costs. These factors raised landed costs for pharmaceutical manufacturers and importers.
The depreciation of the euro also contributed to higher dollar-denominated import costs. Meanwhile, tight availability of diosgenin and other steroidal feedstocks extended lead times from Asian suppliers. As a result, European buyers faced fewer attractive spot offers and increased procurement costs.
Demand remained relatively stable because of continued requirements from clinical and pharmaceutical applications. Safety-stock drawdowns and seasonal restocking also limited aggressive discounting by suppliers.
The European Progesterone Price Trend therefore remained upward during Q2, although broader chemical-market softness and subdued industrial activity provided some counterpressure.
𝐓𝐫𝐚𝐜𝐤 𝐑𝐞𝐚𝐥-𝐓𝐢𝐦𝐞 𝐏𝐫𝐢𝐜𝐞𝐬 𝐎𝐟 𝐏𝐫𝐨𝐠𝐞𝐬𝐭𝐞𝐫𝐨𝐧𝐞
https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Progesterone
Historical Progesterone Price Movement
The global Progesterone Price market had already started showing upward momentum before Q2 2026.
During Q1 2026, China's Progesterone Price Index increased by 3.55% QoQ, with the average price reaching approximately USD 179,313.33/MT FOB Shanghai. Germany recorded a similar 3.55% QoQ increase, with an average price of around USD 179,400/MT. In the United States, the index also increased by 3.55%, reaching approximately USD 179,406.67/MT.
The Q1 increase was connected to tightening diosgenin supplies, stronger export enquiries, environmental inspections, higher solvent costs, and increased pharmaceutical procurement. Fertility-clinic purchasing and public-hospital tenders also provided additional demand support.
In Q4 2025, the market was comparatively stable. The US, China, and Germany each recorded approximately 0.1% QoQ growth, with average prices around USD 173,253.33/MT, USD 173,166.67/MT, and USD 173,248.33/MT, respectively.
At that time, lower China-US freight costs and competitive Asian offers limited price increases in North America. In China, freight inflation and winter environmental controls provided some support, while Germany experienced balanced supply and stable energy costs.
Key Factors Influencing the Progesterone Price
Several factors are expected to remain important for the global Progesterone Price throughout 2026.
Diosgenin and Steroidal Feedstock Availability
Diosgenin availability is a major consideration for progesterone API production. Tight feedstock availability can increase conversion costs and restrict production volumes, particularly when manufacturers are unable to secure sufficient quantities at stable prices.
Freight and Logistics Costs
International freight has become an important component of landed Progesterone Price, particularly for importing regions such as North America and Europe. Higher container rates, insurance premiums, port congestion, and extended transit times can increase the final acquisition cost.
Pharmaceutical Demand
Progesterone is widely used in pharmaceutical formulations associated with hormone replacement, fertility treatment, contraceptive applications, and pregnancy-related therapies. Stable procurement from pharmaceutical manufacturers can provide an underlying source of demand.
Veterinary applications also contribute to market consumption, particularly in regions where progesterone-based products are used in reproductive management.
Environmental Regulations
Environmental inspections and compliance requirements can affect operating rates at chemical and pharmaceutical manufacturing facilities. Temporary production interruptions can reduce spot availability and support higher supplier quotations.
Currency Movements
Currency fluctuations influence international procurement costs. Changes in the US dollar, euro, yuan, and other currencies can alter the landed cost of imported progesterone even when the origin-market price remains relatively stable.
Inventory Levels
Inventory availability remains an important factor in determining short-term market direction. Lean inventories can encourage buyers to replenish earlier and provide suppliers with stronger pricing leverage, while comfortable inventories may reduce immediate purchasing urgency.
Progesterone Production and Supply Chain
Progesterone API is a pharmaceutical-grade active ingredient used in the manufacture of medicines. ChemAnalyst identifies the product as an API supplied in powder form and used in formulations including tablets, injections, and vaginal inserts. The product is commonly synthesized using plant-derived steroidal materials.
The product has CAS No. 57-83-0 and HS Code 2937231020. ChemAnalyst lists IP and USP grades, with facilities approved by CDSCO and USFDA and certifications including GMP, cGMP, and CEP. Drum packaging is commonly used for commercial supply.
The supply chain generally involves steroidal raw materials, conversion and purification, pharmaceutical-grade processing, quality testing, packaging, international transportation, and final delivery to pharmaceutical manufacturers or distributors.
Progesterone Applications
Progesterone is an important steroid hormone and pharmaceutical API. Its commercial applications include:
Hormone replacement therapy
Fertility and assisted reproductive treatments
Contraceptive formulations
Pregnancy-support medicines
Women's healthcare products
Veterinary reproductive applications
Pharmaceutical research and formulation development
Demand from these applications provides a relatively stable consumption base for progesterone API.
Progesterone Price Forecast 2026
The Progesterone Price Forecast for the remainder of 2026 will depend on the interaction between feedstock costs, pharmaceutical demand, production rates, inventories, and logistics.
The Q2 2026 market demonstrated that freight and import costs can have a significant effect on regional pricing. In North America and Europe, higher transportation and insurance expenses increased landed costs even though fundamental production availability remained relatively stable.
In China, the outlook is closely linked to diosgenin availability, environmental inspections, export enquiries, and solvent costs. If feedstock availability remains constrained and international demand stays firm, suppliers may maintain firm quotations.
For India, domestic offtake and inventory levels will remain important. A continuation of inventory drawdowns could support procurement activity, while comfortable stocks could moderate buying urgency.
European prices will remain sensitive to Asian supply, freight rates, currency movements, and pharmaceutical procurement. Similarly, the US market will remain exposed to import parity and trans-Pacific logistics costs.
Overall, the Progesterone Price Trend is expected to remain sensitive to supply-chain conditions during 2026. Feedstock availability, pharmaceutical demand, freight costs, environmental compliance, inventories, and international trade flows will be key variables to monitor.
Conclusion
The Progesterone Price Trend in 2026 strengthened considerably during Q2 across North America, APAC, and Europe. The US market recorded a 12.44% QoQ increase, while China and Germany increased by 12.401% and 12.4275%, respectively. India recorded a more moderate 3.699% increase.
Higher freight and insurance costs, tighter diosgenin availability, environmental inspections, stronger export enquiries, and leaner inventories were among the main factors supporting the market. Meanwhile, steady pharmaceutical demand from hormone replacement, fertility, contraceptive, and veterinary applications provided a stable consumption base.
Going forward, the global Progesterone Price will remain closely linked to steroidal feedstock availability, pharmaceutical procurement, production capacity, inventory levels, freight rates, currency movements, and regulatory conditions. Monitoring these factors will be important for manufacturers, pharmaceutical buyers, traders, and procurement teams assessing progesterone costs throughout 2026.
ChemAnalyst provides price assessments, historical trends, demand-supply information, and market intelligence to help businesses monitor changing commodity and pharmaceutical API markets.
Contact Us:
Address:
420 Lexington Avenue, Suite 300 New York, NY 10170 United States
Phone: +1 332 258 6602
Email: sales@chemanalyst.com
Website: https://www.chemanalyst.com/
LinkedIn: https://www.linkedin.com/company/chemanalyst/
Facebook: https://www.facebook.com/ChemAnalysts/
Twitter: https://x.com/chemanalysts
YouTube: https://www.youtube.com/@chemanalyst
Instagram: https://www.instagram.com/chemanalyst_
Comments
Post a Comment